ArticleJournal of diabetes and metabolic disorders2026
Breast cancer and diabetes mellitus-related mortality among U.S. adults: a 25-year CDC WONDER analysis (1999-2023).
Article in Journal of diabetes and metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer (BC) and diabetes mellitus (DM) frequently coexist, posing significant clinical challenges. Evaluating long-term mortality trends helps assess the impact of healthcare practices and public health policies. This study examines mortality trends involving breast cancer and DM in US adults aged > 25, stratified by demographics and geography. Methods: We conducted a retrospective analysis of CDC WONDER mortality data from 1999 to 2023 for individuals aged ≥ 25 years. BC and DM were identified using ICD-10 codes C50 and E10-E14. Age-adjusted mortality rates (AAMR) per 100,000 were calculated. Joinpoint regression estimated annual percentage changes (APC) with 95% confidence intervals (CI). Results: From 1999 to 2023, 79,139 deaths involving BC and DM. Overall, AAMR remained stable (AAPC 0.23; 95% CI, -0.002 to 0.475, Conclusion: Mortality involving BC and DM has remained largely stable over two decades, but disparities by sex, age, race/ethnicity, and geography persist, highlighting the need for targeted interventions in high-risk populations. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s40200-026-02074-4.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.